Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 May 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Post-transplant lymphoproliferative risk in pancreas recipients

Post-transplant lymphoproliferative in pancreas recipients has a worse prognosis than in other transplant recipients, and these immunosuppressed patients, who often face multiple transplants, may be at greater risk, reports the latest Transplantation.

News image

fiogf49gjkf04

Post-transplant lymphoproliferative disorder is a rare, serious complication of transplantation.

The characteristics and associations of this disease in pancreas recipients have not been extensively studied.

Dr Steven Paraskevas and colleagues performed 787 pancreas and 569 kidney-pancreas transplants from 1988 to 2002 at their institution.

The research team reported that 18 pancreas recipients developed polymorphic posttransplant lymphoproliferative disorder or malignant lymphoma.

Data on clinical course, organ involvement, molecular characteristics was compiled from the institutional transplant database

Cytomegalovirus infection may play an antecedent role
Transplantation

The researchers also compiled data on and association with immunosuppression and recent cytomegalovirus infection.

Patient survival was compared to recipients of liver and kidney transplants at the same center by using Kaplan-Meier analysis.

The researchers found that the 5-year cumulative incidence of posttransplant lymphoproliferative in simultaneous pancreas-kidney recipients was 3%.

The 5-year cumulative incidence of post-transplant lymphoproliferative in pancreas after kidney recipients was 1.2%.

In pancreas transplant alone recipients, the 5-year cumulative incidence of the disease was 1%.

The team noticed a higher, but not significant, cumulative incidence in the more recent era since 1995.

Post-transplant lymphoproliferative in pancreas recipients carried a worse prognosis than in liver or kidney for recipients B-cell.

The researchers also observed that Post-transplant lymphoproliferative had a worse prognosis with early-onset, and Epstein Barr virus-positive lesions.

Posttransplant lymphoproliferative was more aggressive in pancreas recipients, with a higher stage at presentation and a trend to more bone marrow involvement.

The research team noted a tendency toward association with recent cytomegalovirus infection.

Since 1995, the team observed that post-transplant lymphoproliferative recipients have had a lower exposure to antilymphocyte preparations.

Dr Paraskevas' team concludes, “Posttransplant lymphoproliferative in pancreas recipients remains a rare but aggressive disease, and carries a worse prognosis in comparison to other transplant recipients.”

“These heavily immunosuppressed patients, who often face multiple transplants, may be at greater risk; cytomegalovirus infection may play an antecedent role.”

Transpl 2005: 80(5) 613-22
22 September 2005

Go to top of page Email this page Email this page to a colleague

 23 May 2017 
Mother-to-child transmission of hepatitis B virus
 23 May 2017 
Physician burnout and well-being
 23 May 2017 
Genes and pancreatic cancer
 22 May 2017 
Fungal microbiota in IBD
 22 May 2017 
Disease extension in ulcerative colitis
 22 May 2017 
Exercise in dieting obese older adults
 19 May 2017 
Clinical improvement in mild acute pancreatitis
 19 May 2017 
Repeat biopsy and celiac disease outcomes 
 19 May 2017 
Global prevalence of IBS in adults
 18 May 2017 
Genetics and the gut microbiota and metabolic syndrome
 18 May 2017 
Antireflux surgery in extraesophageal reflux
 18 May 2017 
Breath testing in gastrointestinal disorders
 17 May 2017 
ERCP-related radiation cataractogenesis
 17 May 2017 
Satisfactory completion rates in upper GI endoscopy
 17 May 2017 
Tools for assessing dysphagia in eosinophilic esophagitis
 16 May 2017 
Testosterone levels in pre-menopausal women in NAFLD 
 16 May 2017 
UK guideline on GI pediatric to adult transition
 16 May 2017 
Most appropriate delivery mode in women with IBD 
 15 May 2017 
Biopsy after diagnosis in celiac disease
 15 May 2017 
Age and NAFLD diagnosis
 15 May 2017 
GI symptoms in pediatric IBD
 12 May 2017 
Treatment of HCV in liver transplant
 12 May 2017 
Non-vitamin K antagonist oral anticoagulants and GI bleeds
 12 May 2017 
Outcomes after continent ileostomy in Crohn's
 11 May 2017 
Biochemical test for bile acid diarrhea
 11 May 2017 
Biopsy and celiac disease diagnosis
 11 May 2017 
Age and diagnosis of advanced NAFLD fibrosis
 10 May 2017 
Biomarkers for gastric cancer risk assessment
 10 May 2017 
Inflammatory response biomarkers in decompensated cirrhosis
 10 May 2017 
Therapy for NASH
 09 May 2017 
Predicting post-operative Crohn's recurrence
 09 May 2017 
Multidisciplinary approach to pancreas cancer
 09 May 2017 
Hepatic manifestations of IBD
 08 May 2017 
Risk factor for non-obese NAFLD
 08 May 2017 
Central neuromodulators for functional GI Disorders
 08 May 2017 
Chronic liver diseases in the USA
 05 May 2017 
H. pylori infection and preeclampsia
 05 May 2017 
Low-cost oral rotavirus vaccine
 05 May 2017 
 Clostridium difficile and colectomy risk in IBD
 04 May 2017 
Mushroom poisoning and hepatitis
 04 May 2017 
Lean and obese patients with NAFLD
 04 May 2017 
Weight and mortality
 03 May 2017 
Quality and quantity of life in end-stage liver disease
 03 May 2017 
Metabolomes in NASH
 03 May 2017 
Oral direct-acting antivirals for HCV
 02 May 2017 
Transition readiness scores in adolescents with IBD
 02 May 2017 
Hepatocellular carcinoma risk in different etiologies of cirrhosis
 02 May 2017 
IBD disability index
 01 May 2017 
Hepatocellular carcinoma after HCV eradication
 01 May 2017 
Pregnancy and anti-TNF agents in IBD
 01 May 2017 
Functional abdominal pain predicts in children
 28 April 2017 
Yoga for ulcerative colitis
 28 April 2017 
Risk of pain after liver transarterial chemoembolization
 28 April 2017 
Anastomotic leak in colorectal cancer
 27 April 2017 
Precision oncology in liver cancer
 27 April 2017 
Celiac disease in adolescents with susceptibility genotypes
 27 April 2017 
Esophageal endocscopic submucosal dissection
 26 April 2017 
Time to colonoscopy and colorectal cancer
 26 April 2017 
National gastric cancer screening program
 26 April 2017 
Iron formulations for anemia in IBD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us